ImmunoGen, Inc. (Nasdaq: IMGN) announced the pricing of $100 million aggregate principal amount of its 4.50% convertible senior notes due ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Equity Offerings

ImmunoGen Announces Pricing of $100 Million Offering of 4.50% Convertible Senior Notes Due 2021June 15, 2016 8:58 AM Form 8-K IMMUNOGEN INC For: Jun 13June 13, 2016 5:19 PM Immunogen (IMGN) Announces $100M Conv. Senior Note OfferingJune 13, 2016 4:01 PM ImmunoGen Announces Proposed $100 Million Offering of Convertible Senior Notes Due 2021June 13, 2016 4:01 PM